New hope for tough lymphoma: chemo beads target bulky tumors
NCT ID NCT07198230
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with a type of blood cancer called diffuse large B-cell lymphoma that has come back or not responded to standard treatments, especially when they have large tumors. The approach uses tiny beads filled with chemotherapy that are delivered directly to the tumor's blood supply, aiming to shrink the mass. The goal is to see if this local treatment is safe and effective as a salvage option for these hard-to-treat cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Fujian Medical University
RECRUITINGFuzhou, Fujian, 350001, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can an immune booster outsmart brain lymphoma?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can donor immune cells be engineered to fight blood cancer?
- Can a simple blood test spot lymphoma earlier?
- Can a Light-Based device spot dangerous infection risk without a blood draw?